The effect of soy protein on serum lipid profile and some lipid metabolizing enzymes in rats fed with cholesterol diets was examined in this study. Rats were subjected to feeding trial over a period of six weeks on formulated diets containing: 20% soy protein with 0% cholesterol (group A); 20% soy protein with 5% cholesterol (group B), 20% soy protein with 10% cholesterol (group C), 0% soy protein with 20% cholesterol (group D), and 5% soy protein with 20% cholesterol (group E).
INTRODUCTION
It is well known that cardiovascular disease (CVD) is the leading cause of death in both men and women in developed countries1. Hypercholesterolemia has been established as a primary risk factor in the development of CVD. Studies in this area are mostly preventive and have focused on ways of reducing serum cholesterol by nutritional means. Preventing or reducing the increase in serum cholesterol is associated with reducing risk for CVD. Diet plays an important role in controlling blood lipids. Although elevation of serum or tissue cholesterol after excessive cholesterol intake depends on the animal species, cholesterol administration has been shown to increase total cholesterol in rats 1 . The hypercholesterolemia that develops when animals are fed on high fat diet is consistently characterized by an increase in the molecular weight of serum low density lipoproteins (LDL) 2 , 3 . The hypercholesterolemic effect of soy protein has been recognized for more than thirty years 4 . Animal studies show that substituting soy protein for dietary animal protein reduces serum total and LDL cholesterol concentrations 5 . The magnitude of the cholesterol lowering effect of soy protein is similar to that observed for other plant-based foods such as oat bran, or garlic and has been confirmed to be a major clinical means of treating patients with genetically based hypercholesterolemia 6 . However, the real potential of soy protein appears to be preventing the rise in serum cholesterol which is diet-induced in almost 40% of the adult population and therefore in lowering the overall risk for CVD.
Changes in serum lipids are controlled by those enzymes responsible for lipid metabolism; Lipoprotein lipase (LPL) is the crucial enzyme in the metabolism of triglyceride rich lipoproteins. Elevated triglyceride rich lipoprotein levels not only may promote a more rapid progression of atherosclerosis, but could also lead to myocardial ischemia particularly in subjects with high triglyceride/low HDL traits which is frequently present in coronary artery disease (CAD) 7 . Earlier reports have shown that sub endothelially located LPL exhibited proatherogenic effect by increasing oxidative susceptibility of LDL facilitating the uptake of triglyceride rich lipoproteins by macrophages 8 . The latter promotes foam cell formation 9 which is the hallmark of atherogenesis 10 .
Lecithin: Cholesterol acyl transferase (LCAT) is a serum enzyme that esterifies free cholesterol, primarily at the surface of the HDL particle after which the cholesteryl ester molecules migrate to the inner core of this lipoprotein. Through this action, LCAT plays a key role in the maturation of HDL particles 11 . In humans, almost all serum cholesteryl esters are formed by the activity of LCAT 11 , 12 and individuals devoid of this enzyme show abnormal plasma lipoproteins 13 . Experimental findings have indicated that modification of serum proteins by LCAT alters rates of cholesterol flux between cells and medium and results in a net loss of cholesterol from the cells accompanied by cellular cholesterol synthesis 14 , 15 , 16 . Studies have shown that an increased activity of LCAT is proatherogenic 17 , 18 .
High levels of serum triglyceride has been strongly linked with low serum HDL cholesterol 19 , 20 and these low HDL Levels may contribute to increased risk for CVD 21 . Triglyceride lipase is a major factor in the reduction of serum triglyceride concentration 22 .
The enzymes: Lipoprotein lipase (LPL), LCAT and triglyceride lipase (TGL) have been hypothesized to participate in the regulation of cholesterol metabolism. This hypothesis coupled with the effect of soy protein on serum lipid profile is explored in this present study.
MATERIALS AND METHODS
Materials : All chemicals and reagents used were of analytical grade and are all products of either BDH Chemicals Limited, Poole, England or New England Nuclear Corp, Boston, MA, U.S.A.
Soy Protein: Matured soy beans (uncooked) were purchased from Iwaro Market, Oka Akoko, Ondo State, Nigeria and was identified as Glycine maximus (soybean) by a taxonomist in the Department of Crop Science, Faculty of Agriculture, University of Benin, Nigeria. This was ground into powder and used in the diet formulation. Some of the soy protein was subsequently dropped at the herbarium of the faculty. Animals and Diets: Thirty five (35) twelve weeks old albino rats (Wistar Strain) weighing between 60-70Kg purchased from the animal house of the department of Biochemistry, University of Ilorin, Nigeria were used for the study. The rats were housed in stainless steel cages with raised wire floors at a temperature of 30 degrees centigrade and fed on rat chow and water ad libidum for a period of two weeks to acclimatize. The animals were then divided into five groups of seven rats each designated A (control), B, C, D & E (experimentals) were then placed on five different dietary regimen as showed in table 1. Before the commencement of the dietary regimen, the animals were fasted overnight but allowed access to water ad libitum. One rat from each group was sacrificed on Day 0 and each serum collected to determine the baseline level of the test parameters studied. Serum Preparation: At weekly intervals, one rat from each group was sacrificed and 2ml of blood was collected from the animal by cardiac puncture. The blood was allowed to stand at room temperature to clot and centrifuged at 10,000g for 5minutes using Hettich (Universal II) centrifuge to separate serum from the cells. The supernatant (serum) was carefully decanted and analysis was carried out immediately.
Assays: Determination of total and free cholesterol in the serum was by the method of Searcy and Bergquist 23 . Serum triglyceride (TG) was determined using the method of Tiez 24 after enzymatic hydrolysis by lipases LDL and HDLcholesterol were determined according to the methods described by Friedwald et al 25 while VLDL-cholesterol was calculated using Friedwald et al 25 formular. Protein content was determined by the Biuret reaction 26 while lipoprotein lipase and triglyceride lipase activities were determined by the method of Kamimura et al (1999) 27 . LCAT activity was determined by the methods described by Varma and Soloff (1976) 28 . Lipoprotein lipase and triglyceride lipase activity were measured in mmol of free fatty acids liberated per minute while LCAT activity was expressed in mg cholesterol ester formed per 100ml serum.
Statistical Analysis: Statistical analysis was done by one way analysis of variance (ANOVA) and Duncan Multiple range test (DMRT).
RESULTS
The animals consumed their daily rations satisfactorily and showed increase in their body weight. The weekly percentage increase in body weight for the respective groups is presented in Table 2 below. Table 3 shows the weekly changes in serum total, free, esterified,VLDL-,LDL-, and HDL-cholesterol concentration observed for the respective groups over the six weeks treatment period.Results obtained indicate that rats in groups B and C fed 20% soy protein with 5% and 10% cholesterol respectively showed decreases in their serum cholesterol levels when compared to the control while groups D and E rats fed 20% cholesterol with 0% and 5% soy protein respectively showed significant increases (p<0.05,p<0.01) in their serum cholesterol levels when compared to the control and groups B and C. Generally, the reduction in group B rats was statistically significant (p<0.05) when compared to the control and in all the cholesterol fractions. Group E (5% soy protein + 20% cholesterol) rats however had reduced cholesterol fraction levels (p<0.05) when compared to group D rats (0% soy protein + 20% cholesterol). Table 4 shows the changes in the serum triglyceride concentration for the respective groups studied. Although there was no significant mean difference in group B and C rats (p>0.05), group D rats fed 20% cholesterol without soy protein showed significantly elevated levels of serum triglyceride (p<0.05). Table 5 shows lipoprotein lipase activity (expressed in mmol of free fatty acid hydrolysed per minute )for the respective groups over the six week period. Rats in groups B, C, D and E showed a significant increase (p<0.05) in their serum lipoprotein lipase activity when compared to the control. The enzyme activity in group D is about 2-folds that of the control and inclusion of soy protein showed significant reduction (p<0.05) in the activity of LPL when compared to group D rats The esterifying activity of serum LCAT expressed as mg cholesterol ester formed per 100ml serum is as shown in Table 6 . The results obtained showed that rats in groups D and E fed 20% cholesterol with 0% soy protein and 5 % soy protein respectively showed about 3-fold and 2.5-fold respectively increase in activity when compared to the control rat at the end of the feeding trial.Though rats in groups B , C, D ,and E showed a significant increase (p<0.05) in LCAT activity when compared with the control, higher activity was observed in group D when compared with groups B and C. Table 7 shows the results obtained for serum triglyceride lipase (TGL) activity for the respective groups. At the end of the feeding trial rats in group D showed elevated levels in serum triglyceride lipase (TGL) (p<0.01) when compared comparedto the control.The groups on soy protein supplementation (groups B and C) showed significantl reduction (p<0.05) in TGL levels when compared to group D (0% soy protein +20% cholesterol). 
DISCUSSION
Cholesterol rich diet has been demonstrated by several workers to increase serum total, VLDL and LDLcholesterol as well as serum triglyceride concentrations 3 , 18 , 29 . Contrary to the expected elevation of serum total cholesterol, VLDL cholesterol, LDL cholesterol and triglyceride concentrations, the results obtained from this study show decreased total VLDL and LDL cholesterol as well as triglyceride concentrations. The results obtained for groups B and C rats showed reductions in their serum total, VLDL and LDL cholesterol concentration as well as triglyceride concentrations. This could be attributable to the inclusion of 20% soy protein in the animal diet. This observation is justifiable since group D rats fed diet containing no soy protein showed significantly (p<0.05) raised levels serum total cholesterol, VLDL cholesterol, LDL cholesterol and triglyceride concentrations, while group E rats fed diet containing 5% soy protein showed significant decrease (p<0.05) in their serum total, VLDL and LDL cholesterol concentration as well as triglyceride concentrations when compared group D rats. This results further strengthens the earlier reports on the hypocholesterolemic effect of soy protein 4 , 5 .
Comparative clinical trials by Anderson et al 30 , showed than consumption of diets rich in soy protein as opposed to those high in animal protein significantly lowers blood total cholesterol level, LDL cholesterol and triglycerides without lowering helpful HDL cholesterol. Kirk et al 31 have also demonstrated that diet containing intact or unextracted soy protein significantly reduces lesion areas in wild type mice when compared to those fed phytooestrogen extracted soy protein 31. They equally observed that there was no difference in the extent of atherosclerosis in the LDL receptor deficient mice fed intact soy protein and those fed phytoestrogen extracted soy protein. This suggests that cellular LDL receptors play a significant role in soy protein hypocholesterolemic effect 32 . The activities of lipid metabolizing enzymes especially lipoprotein lipase, LCAT and triglyceride lipase have been reported to be responsive to nutritional factors 19 , 33 . Exogenous cholesterol does contribute significantly in the regulation of the activities of these enzymes. Hypertriglyceridemia, a major risk factor for CVD has been demonstrated to be associated with increased LPL and TGL activity 19 , 22 , 34 . Similarly, variation in the serum level of HDL cholesterol has been reportedly linked to the activity of LPL and TGL 19 , 20 , 34 . Low levels of HDL cholesterol observed in patients at high risk of CVD have been associated with increased LPL and TGL activities. The result of our present study shows that consumption of soy protein reduces to baseline levels serum LPL and TGL activity. Earlier reports by Onyeneke et al 18 and Ononugbu et al 17 have demonstrated that increased LCAT activity is proatherogenic. The results obtained from this study supports this claim, This is justified since group D rats fed diets containing 0% soy protein with 20% cholesterol showed significantly higher LCAT activity when compared with group B and C rats fed 20% soy protein. The action of soy protein on the activity of these lipid metabolizing enzymes could be attributable to its hypocholesterolemic effect. Thus, reduction in serum levels of cholesterol and triglycerides may lead to a corresponding decrease in the activity of these enzymes. It is therefore suggested that the inclusion of soy protein in the diet improves serum lipid profile as well as control the activities of the lipid metabolizing enzymes. Hence, soy protein will be beneficial in reducing the increased risk to and consequent death (resulting from intake of high fat diet) due to atherosclerosis.
